Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cancer cell DNA refers to the genetic material within cancerous cells that has undergone mutations or structural changes, leading to uncontrolled cell growth and division. These alterations in DNA are central to the transformation of normal cells into cancer cells and drive many of the hallmarks of cancer, such as unchecked proliferation, evasion of apoptosis (programmed cell death), and genomic instability. Therapies increasingly target features unique to cancer cell DNA, such as defective repair pathways or specific mutated sequences.
Various mechanisms depending on the drug. PARP inhibitors target DNA repair pathways. Chemotherapy drugs induce DNA damage. Genome editing tools modify specific DNA sequences.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cancer Cell DNA.